Public Notification: L-Carnitine Sob Strengthening Version Slimming Miracle Capsule contains hidden drug ingredient [3-5-2015] The Food and Drug Administration (FDA) is advising consumers not to purchase or use L-Carnitine Sob Strengthening Version Slimming Miracle Capsule, a product promoted for weight loss
Arner, E
Patent expirations, generics competition, and a global surge in metabolic drug development could dramatically increase the number of trials targeting obesity and metabolic disease
Food and Drug Administration in 2024 as a warning ( Retrospective cohort study of obese or T2DM patients reported cases showing no linkor even improvementin suicidality, with reduced risk of sudden or recurrent suicidal thoughts ( 5 State of the art and future directions No clear causal mechanism linking GLP-1 RA use to suicidality has been established
2025 systematic review in HSS Journal screened the full BPC-157 musculoskeletal literature through June 2024 and found a large preclinical base tendon, ligament, muscle, bone, and nerve injury models but only one published human exposure dataset, the small open-label knee-pain case series
Federal regulators will be the next stop as the deal moves toward closure, which is anticipated to be around early 2025